X-linked hypophosphatemic rickets and nephrocalcinosis: clinical characteristics of a single-center pediatric cohort in North America before and after burosumab

BackgroundX-linked hypophosphatemic rickets (XLH) is a rare genetic disease characterized by inappropriately elevated circulating fibroblast growth factor 23 (FGF-23) and subsequent urinary phosphate wasting. The primary clinical manifestations of XLH include short stature, lower extremity bowing, d...

Full description

Bibliographic Details
Published in:	Frontiers in Pediatrics
Main Authors:	Neil J. Paloian, Lindsey R. Boyke-Lohmann, Robert D. Steiner
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-08-01
Subjects:	XLH rickets hypophosphatemia nephrocalcinosis burosumab
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2024.1430921/full

Similar Items

Erratum: X-linked hypophosphatemic rickets and nephrocalcinosis: clinical characteriscs of a single-center pediatric cohort in North America before and after burosumab
by: Frontiers Production Office
Published: (2024-11-01)

Nephrocalcinosis tendency does not worsen under burosumab treatment for X-linked hypophosphatemic rickets: a multicenter pediatric study
by: Shelly Levi, et al.
Published: (2024-12-01)

Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia
by: Silvia Martín Ramos, et al.
Published: (2020-02-01)

X-linked hypophosphatemia and tumor-induced osteomalacia: a narrative review and expert opinion on the diagnostic and therapeutic challenges in the era of burosumab
by: Maria Luisa Brandi, et al.
Published: (2025-10-01)

Burosumab - new potent treatment for X-linked hypophosphatemia and tumor-induced osteomalacia
by: Magda Wojtuś, et al.
Published: (2023-07-01)

Lessons learned from the real-world diagnosis and management of hereditary hypophosphatemic rickets
by: Deepti Chaturvedi, et al.
Published: (2024-06-01)

Complications and Treatments in Adult X-Linked Hypophosphatemia
by: Yasuo Imanishi, et al.
Published: (2022-09-01)

Impact of burosumab on lower limb alignment in children with X-linked hypophosphatemia
by: David B. Frumberg, MD, FAAOS, et al.
Published: (2024-02-01)

X-linked hypophosphatemic rickets: from diagnosis to management
by: Eujin Park, et al.
Published: (2024-01-01)

Hypophosphatemic Rickets in Patients from Bichoric Biamniotic Twins: A Case Report
by: Anna S. Nechaeva, et al.
Published: (2025-02-01)

Hypophosphatemic rickets: An unexplained early feature of craniometaphyseal dysplasia
by: Julio Soto Barros, et al.
Published: (2023-12-01)

X - Linked Hypophosphatemic Rickets: A diagnostic and therapeutic challenge
by: Guerrero Tinoco, Gustavo Adolfo, et al.
Published: (2021-07-01)

The importance of early diagnosis of X-linked hypophosphatemic rickets: a case report
by: Francesca Franchina, et al.
Published: (2024-07-01)

FGF23, Hypophosphatemia, and Emerging Treatments
by: Erik A Imel, et al.
Published: (2019-08-01)

Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome
by: Lillian Abebe, et al.
Published: (2024-03-01)

X‐linked hypophosphatemic rickets: Case report of late diagnosis and bone pain improvement with targeted treatment
by: Marcia Janneth Bermeo Cabrera, et al.
Published: (2022-08-01)

Family analysis and literature study of hereditary hypophosphatemic rickets with hypercalciuria
by: Lufeng Wang, et al.
Published: (2024-02-01)

The Possible Outcomes of Poor Adherence to Conventional Treatment in Patients with X-Linked Hypophosphatemic Rickets/Osteomalacia
by: Hiroaki Zukeran, et al.
Published: (2023-02-01)

Concordant X-linked hypophosphatemic rickets in monozygotic twins: diagnostic challenges and a novel genetic insight
by: Sara Ribeiro, et al.
Published: (2025-09-01)

Efficacy and safety of burosumab compared with conventional therapy in patients with X-linked hypophosphatemia: A systematic review
by: Manjunath Havalappa Dodamani, et al.
Published: (2024-06-01)

Impact of stopping burosumab treatment at the end of skeletal growth in adolescents with X-linked hypophosphatemia (XLH)
by: Charlotte Jarvis, et al.
Published: (2025-03-01)

Mineralization Defects in the Primary Dentition Associated With X‐Linked Hypophosphatemic Rickets
by: Delaney Clayton, et al.
Published: (2021-04-01)

Clinical, Radiographic, and Molecular Analysis of Patients with X-Linked Hypophosphatemic Rickets: Looking for Phenotype–Genotype Correlation
by: Marco A. Olivas-Valdez, et al.
Published: (2025-01-01)

Hypophosphatemic rickets: pathogenesis, diagnosis and treatment
by: Kristina S. Kulikova, et al.
Published: (2018-07-01)

A novel c.2179T>C mutation blocked the intracellular transport of PHEX protein and caused X‐linked hypophosphatemic rickets in a Chinese family
by: Baowei Li, et al.
Published: (2020-08-01)

Meta-analysis and systematic review: burosumab as a promising treatment for children with X-linked hypophosphatemia
by: Kangning Wang, et al.
Published: (2024-08-01)

FGF23‐related hypophosphatemic rickets preceding the onset of systemic lupus erythematosus: A juvenile case
by: Yoko tabei, et al.
Published: (2024-01-01)

De Novo Large Deletions in the <i>PHEX</i> Gene Caused X-Linked Hypophosphataemic Rickets in Two Italian Female Infants Successfully Treated with Burosumab
by: Carmine Pecoraro, et al.
Published: (2023-07-01)

Real‐world data of Brazilian adults with X‐linked hypophosphatemia (XLH) treated with burosumab and comparison with other worldwide cohorts
by: Maria Helena Vaisbich, et al.
Published: (2024-02-01)

Dental manifestations of patient with Vitamin D-resistant rickets
by: Andreia Pereira SOUZA, et al.
Published: (2013-12-01)

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data
by: Gema Ariceta, et al.
Published: (2023-09-01)

Case Report: Increased FGF23 and new insufficiency fractures at burosumab discontinuation in X-linked hypophosphatemia
by: Robert Bandir, et al.
Published: (2025-10-01)

A Case of Tumor-Induced Osteomalacia Detected by Venous Sampling
by: Horinouchi Y, et al.
Published: (2023-10-01)

Improvements with burosumab treatment in an early access programme for adults with X-linked hypophosphataemia: A case series of three patients
by: Julia Day, et al.
Published: (2024-12-01)

Endodontic treatment in patients with X-linked hypophosphatemic rickets
by: Cleverton Roberto de Andrade, et al.
Published: (2015-10-01)

Nationwide Turkish Cohort Study of Hypophosphatemic Rickets
by: Zeynep Şıklar, et al.
Published: (2020-06-01)

Comprehensive Metabolomic Profiling in Adults with X-Linked Hypophosphatemia: A Case-Control Study
by: Luis Carlos López-Romero, et al.
Published: (2024-12-01)

X-linked hypophosphatemic rickets: a new mutation
by: Patrícia Maio, et al.
Published: (2020-09-01)

Osteocytes and the pathogenesis of hypophosphatemic rickets
by: Miwa Yamazaki, et al.
Published: (2022-09-01)

HYPOPHOSPHATEMIC RICKETS
by: N. N. Kartamysheva, et al.
Published: (2013-07-01)